子宫体癌。《国际妇产科联盟第26届妇科癌症治疗结果年度报告》 - Suppr

Suppr

超能文献

Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.

作者信息

Creasman W T, Odicino F, Maisonneuve P, Quinn M A, Beller U, Benedet J L, Heintz A P M, Ngan H Y S, Pecorelli S

出版信息

Int J Gynaecol Obstet. 2006 Nov;95 Suppl 1:S105-43. doi: 10.1016/S0020-7292(06)60031-3.

DOI:10.1016/S0020-7292(06)60031-3

PMID:17161155

Abstract

摘要

相似文献

Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.

Int J Gynaecol Obstet. 2006 Nov;95 Suppl 1:S105-43. doi: 10.1016/S0020-7292(06)60031-3.

Carcinoma of the fallopian tube. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.

Int J Gynaecol Obstet. 2006 Nov;95 Suppl 1:S145-60. doi: 10.1016/S0020-7292(06)60032-5.

Carcinoma of the vulva. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.

Int J Gynaecol Obstet. 2006 Nov;95 Suppl 1:S7-27. doi: 10.1016/S0020-7292(06)60028-3.

Carcinoma of the vagina. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.

Int J Gynaecol Obstet. 2006 Nov;95 Suppl 1:S29-42. doi: 10.1016/S0020-7292(06)60029-5.

Carcinoma of the ovary. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.

Int J Gynaecol Obstet. 2006 Nov;95 Suppl 1:S161-92. doi: 10.1016/S0020-7292(06)60033-7.

Carcinoma of the cervix uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.

Int J Gynaecol Obstet. 2006 Nov;95 Suppl 1:S43-103. doi: 10.1016/S0020-7292(06)60030-1.

Gestational trophoblastic neoplasia. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.

Int J Gynaecol Obstet. 2006 Nov;95 Suppl 1:S193-203. doi: 10.1016/S0020-7292(06)60034-9.

Overview of cervical cancer in the developing world. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.

Int J Gynaecol Obstet. 2006 Nov;95 Suppl 1:S205-10. doi: 10.1016/S0020-7292(06)60035-0.

Carcinoma of the corpus uteri.

J Epidemiol Biostat. 2001;6(1):47-86.

Endometrial carcinoma in the baby boomer generation. Tumor characteristics and clinical outcome.

Anticancer Res. 2013 Feb;33(2):619-24.

引用本文的文献

NXF1 suppresses progression of endometrial cancer by interacting with the SRSF3 to regulate SP4 splicing.

iScience. 2025 Jul 22;28(8):113113. doi: 10.1016/j.isci.2025.113113. eCollection 2025 Aug 15.

Unveiling the intricacies: small interfering RNA targeting Snail-1 unravels dynamics in endometrial carcinoma cell behavior.

Front Oncol. 2025 Jun 12;15:1567493. doi: 10.3389/fonc.2025.1567493. eCollection 2025.

PD-1 or PD-L1 inhibitors in addition to first-line chemotherapy for endometrial cancer: an extracted individual patient data meta-analysis.

Ecancermedicalscience. 2025 Apr 1;19:1884. doi: 10.3332/ecancer.2025.1884. eCollection 2025.

Subsequent cancers following non-myeloablative conditioning for allogeneic hematopoietic cell transplantation.

Bone Marrow Transplant. 2025 Jul;60(7):1052-1056. doi: 10.1038/s41409-025-02606-1. Epub 2025 Apr 26.

Identification of key pathways and molecular players potentially involved in endometrial cancer metastasis through integrated bioinformatics analyses.

Bioimpacts. 2024 Jun 26;15:30222. doi: 10.34172/bi.30222. eCollection 2025.

Low-Grade Endometrial Cancer with Abnormal p53 Expression as a Separate Clinical Entity: Insights from RNA Sequencing and Immunohistochemistry.

Diagnostics (Basel). 2025 Mar 10;15(6):671. doi: 10.3390/diagnostics15060671.

Uterus transplantation: A clinical breakthrough after systematic preclinical research.

Reprod Med Biol. 2025 Feb 11;24(1):e12636. doi: 10.1002/rmb2.12636. eCollection 2025 Jan-Dec.

Subsequent Cancers following Non-myeloablative Conditioning for Allogeneic Hematopoietic Cell Transplantation.

Res Sq. 2025 Jan 8:rs.3.rs-5760731. doi: 10.21203/rs.3.rs-5760731/v1.

Rare massive thoracic metastasis of endometrial cancer: Chest wall demolition and reconstruction. A case report.

Int J Surg Case Rep. 2025 Feb;127:110825. doi: 10.1016/j.ijscr.2025.110825. Epub 2025 Jan 4.

Evaluation of One Step Nucleic Acid Amplification for detection of lymph node metastases compared to histopathological ultrastaging in women with endometrial cancer: a protocol for a diagnostic accuracy study.

BMC Womens Health. 2025 Jan 9;25(1):12. doi: 10.1186/s12905-025-03550-4.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.

作者信息

Creasman W T, Odicino F, Maisonneuve P, Quinn M A, Beller U, Benedet J L, Heintz A P M, Ngan H Y S, Pecorelli S

出版信息

Int J Gynaecol Obstet. 2006 Nov;95 Suppl 1:S105-43. doi: 10.1016/S0020-7292(06)60031-3.

DOI:10.1016/S0020-7292(06)60031-3

PMID:17161155

Abstract

摘要

相似文献

Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.

Int J Gynaecol Obstet. 2006 Nov;95 Suppl 1:S105-43. doi: 10.1016/S0020-7292(06)60031-3.

Carcinoma of the fallopian tube. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.

Int J Gynaecol Obstet. 2006 Nov;95 Suppl 1:S145-60. doi: 10.1016/S0020-7292(06)60032-5.

Carcinoma of the vulva. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.

Int J Gynaecol Obstet. 2006 Nov;95 Suppl 1:S7-27. doi: 10.1016/S0020-7292(06)60028-3.

Carcinoma of the vagina. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.

Int J Gynaecol Obstet. 2006 Nov;95 Suppl 1:S29-42. doi: 10.1016/S0020-7292(06)60029-5.

Carcinoma of the ovary. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.

Int J Gynaecol Obstet. 2006 Nov;95 Suppl 1:S161-92. doi: 10.1016/S0020-7292(06)60033-7.

Carcinoma of the cervix uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.

Int J Gynaecol Obstet. 2006 Nov;95 Suppl 1:S43-103. doi: 10.1016/S0020-7292(06)60030-1.

Gestational trophoblastic neoplasia. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.

Int J Gynaecol Obstet. 2006 Nov;95 Suppl 1:S193-203. doi: 10.1016/S0020-7292(06)60034-9.

Overview of cervical cancer in the developing world. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.

Int J Gynaecol Obstet. 2006 Nov;95 Suppl 1:S205-10. doi: 10.1016/S0020-7292(06)60035-0.

Carcinoma of the corpus uteri.

J Epidemiol Biostat. 2001;6(1):47-86.

Endometrial carcinoma in the baby boomer generation. Tumor characteristics and clinical outcome.

Anticancer Res. 2013 Feb;33(2):619-24.

引用本文的文献

NXF1 suppresses progression of endometrial cancer by interacting with the SRSF3 to regulate SP4 splicing.

iScience. 2025 Jul 22;28(8):113113. doi: 10.1016/j.isci.2025.113113. eCollection 2025 Aug 15.

Unveiling the intricacies: small interfering RNA targeting Snail-1 unravels dynamics in endometrial carcinoma cell behavior.

Front Oncol. 2025 Jun 12;15:1567493. doi: 10.3389/fonc.2025.1567493. eCollection 2025.

PD-1 or PD-L1 inhibitors in addition to first-line chemotherapy for endometrial cancer: an extracted individual patient data meta-analysis.

Ecancermedicalscience. 2025 Apr 1;19:1884. doi: 10.3332/ecancer.2025.1884. eCollection 2025.

Subsequent cancers following non-myeloablative conditioning for allogeneic hematopoietic cell transplantation.

Bone Marrow Transplant. 2025 Jul;60(7):1052-1056. doi: 10.1038/s41409-025-02606-1. Epub 2025 Apr 26.

Identification of key pathways and molecular players potentially involved in endometrial cancer metastasis through integrated bioinformatics analyses.

Bioimpacts. 2024 Jun 26;15:30222. doi: 10.34172/bi.30222. eCollection 2025.

Low-Grade Endometrial Cancer with Abnormal p53 Expression as a Separate Clinical Entity: Insights from RNA Sequencing and Immunohistochemistry.

Diagnostics (Basel). 2025 Mar 10;15(6):671. doi: 10.3390/diagnostics15060671.

Uterus transplantation: A clinical breakthrough after systematic preclinical research.

Reprod Med Biol. 2025 Feb 11;24(1):e12636. doi: 10.1002/rmb2.12636. eCollection 2025 Jan-Dec.

Subsequent Cancers following Non-myeloablative Conditioning for Allogeneic Hematopoietic Cell Transplantation.

Res Sq. 2025 Jan 8:rs.3.rs-5760731. doi: 10.21203/rs.3.rs-5760731/v1.

Rare massive thoracic metastasis of endometrial cancer: Chest wall demolition and reconstruction. A case report.

Int J Surg Case Rep. 2025 Feb;127:110825. doi: 10.1016/j.ijscr.2025.110825. Epub 2025 Jan 4.

BMC Womens Health. 2025 Jan 9;25(1):12. doi: 10.1186/s12905-025-03550-4.